Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Romosozumab on Bone Density, Markers of Bone Metabolism and Bone Microarchitecture in Women With Anorexia Nervosa: A Pilot Study

NCT04779216 is registered in ClinicalTrials.gov with Karen Klahr Miller, MD as lead sponsor.

NCT NCT04779216
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04779216 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Romosozumab on Bone Density, Markers of Bone Metabolism and Bone Microarchitecture in Women With Anorexia Nervosa: A Pilot Study
Lead sponsor
Karen Klahr Miller, MD
Phase
Phase 3
Overall status
Completed
Start date
September 20, 2021
Completion date
November 17, 2025
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anorexia nervosa, bone density, low, bone loss, eating disorders